Technology area: Biotechnology & Pharmaceuticals
30 pending office actions • 20 art units • 30 examiners • 0 of 30 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
The Chinese University of Hong Kong manages 29 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 29 actions are split among 29 distinct examiners, meaning every pending case is being reviewed by a different person. The portfolio is also diversified across 20 distinct art units, reflecting a range of research and development activities.
GHAZAL SABOUR is the busiest examiner for the university, with 1 pending office action. Because there is no concentration of cases with any single examiner, the university must manage 29 independent prosecution tracks. The 20 art units further complicate the prosecution landscape, as the university must navigate the specific requirements of many different technical divisions. This decentralized structure for 29 pending actions requires a coordinated legal effort to maintain a unified patent strategy across 20 art units. This variety in examiners and art units suggests that the university must maintain a flexible prosecution strategy to address the different standards across 20 distinct art units.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 9 (30%) |
| §103 only | 10 (33%) |
| §112 only | 1 (3%) |
| Double-patenting + other | 1 (3%) |
| Multi-statute (no §101) | 9 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SABOUR, GHAZAL | 1 | 37.8% | +43.2% |
| OAKES, JUSTIN MONTGOMERY | 1 | — | — |
| HSIEH, PING Y | 1 | 79.1% | +15.4% |
| FIEBIG, RUSSELL G | 1 | 62.6% | +25.0% |
| COLE, HOUSTON DAVID | 1 | — | — |
| PALLAY, MICHAEL B | 1 | 55.8% | +34.0% |
| DEVI, SARVAMANGALA | 1 | 65.3% | +55.3% |
| MATHEW, SEEMA | 1 | 71.4% | +26.1% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 29.6% | +37.1% |
| JAUHARI, SACHI | 1 | 60.0% | +80.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17814911 | LOW-CONCENTRATION ATROPINE FOR MYOPIA PREVENTION (LAMP-2) STUDY | SHOWALTER, ALEXANDER KEITH | 56d overdue |
| 17247153 | Methods for Inducing Intermittent Fasting and Modulating Autophagy | DABKOWSKI, ERINNE R | 46d overdue |
| 18763336 | SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM | FIEBIG, RUSSELL G | — |
| 18667437 | COMPOSITIONS AND METHODS RELATED TO PROTEIN LABELING | COLE, HOUSTON DAVID | — |
| 18658479 | NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS | PALLAY, MICHAEL B | — |
| 18654339 | COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT | DEVI, SARVAMANGALA | — |
| 18597485 | MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS | MATHEW, SEEMA | — |
| 18443879 | EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19272962 | NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION | SABOUR, GHAZAL | 36d |
| 19004686 | FUSIONNET AND ENSEMBLE LEARNING-BASED ARTIFICIAL INTELLIGENCE SYSTEM FOR ALZHEIMER'S DISEASE CLASSIFICATION FROM OPTICAL COHERENCE TOMOGRAPHY THICKNESS AND DEVIATION MAPS | HSIEH, PING Y | — |
| 18763336 | SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM | FIEBIG, RUSSELL G | — |
| 18658479 | NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS | PALLAY, MICHAEL B | — |
| 18654339 | COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT | DEVI, SARVAMANGALA | — |
| 18597485 | MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS | MATHEW, SEEMA | — |
| 18443879 | EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 18394367 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | JAUHARI, SACHI | — |
| Art Unit | Apps |
|---|---|
| 1686 | 3 |
| 1682 | 3 |
| 1654 | 2 |
| 2662 | 1 |
| 1617 | 1 |
| 1645 | 1 |
| 3774 | 1 |
| 1762 | 1 |
| 1677 | 1 |
| 2874 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19272962 | NON-INVASIVE DETECTION OF TISSUE ABNORMALITY USING METHYLATION | SABOUR, GHAZAL | 1686 | §103 | Non-Final OA | 36d | Pending | Jul 17, 2025 |
| 19069744 | A METHOD OF ENHANCING DATASET FOR USE IN A MEDICAL DIAGNOSTIC SYSTEM, A METHOD FOR TRAINING A MEDICAL DIAGNOSTIC SYSTEM, AND A METHOD OF SYNTHESIZING VIDEO FOR MEDICAL DIAGNOSIS | OAKES, JUSTIN MONTGOMERY | 2662 | §103 | Non-Final OA | — | Pending | Mar 04, 2025 |
| 19004686 | FUSIONNET AND ENSEMBLE LEARNING-BASED ARTIFICIAL INTELLIGENCE SYSTEM FOR ALZHEIMER'S DISEASE CLASSIFICATION FROM OPTICAL COHERENCE TOMOGRAPHY THICKNESS AND DEVIATION MAPS | HSIEH, PING Y | — | §103 | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18763336 | SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM | FIEBIG, RUSSELL G | — | §103§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18667437 | COMPOSITIONS AND METHODS RELATED TO PROTEIN LABELING | COLE, HOUSTON DAVID | — | §103§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18658479 | NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS | PALLAY, MICHAEL B | 1617 | §103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18654339 | COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER TREATMENT | DEVI, SARVAMANGALA | 1645 | §101§102§103 | Non-Final OA | — | Pending | May 03, 2024 |
| 18597485 | MODULAR FOOT CONTROLLED CABLE ACTUATED PROSTHESIS | MATHEW, SEEMA | 3774 | §102§103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18443879 | EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE | FONSECA LOPEZ, FRANCINI ALVARENGA | — | §101§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18394367 | METHOD FOR REVERSING BODY-WIDE AGE-ASSOCIATED FUNCTIONAL CHANGES | JAUHARI, SACHI | 1654 | §102§103§112DP | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18540667 | METHODS AND COMPUTER PRODUCTS FOR MEASURING THE AMOUNT OF CELLS OF A PARTICULAR CELL LINEAGE | MYERS, CARLA J | 1682 | §101§112DPOther | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18495414 | ADRM1/RPN13 SPLICED VARIANT IN THE PROGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA | TURPIN, ZACHARY MARK | 1682 | §101§103§112 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18477775 | CHAOTROPES-ASSISTED DEEP IMMUNOSTAINING | NILAND, PATRICK DENNIS | 1762 | §102§103 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18243349 | RAPID SCREENING METHODS FOR THYROID ASSOCIATED ORBITOPATHY | HOFFMAN, ALEXANDER JOSEPH | 1677 | §103 | Final Rejection | — | Pending | Sep 07, 2023 |
| 18278594 | HIGH COUPLING EFFICIENCY BLAZED WAVEGUIDE GRATING COUPLER | ENDRESEN, KIRSTEN DANIELA | 2874 | §102§103 | Final Rejection | — | Pending | Aug 23, 2023 |
| 18257745 | A METHOD FOR REVERSING AGING BRAIN FUNCTIONAL DECLINE | LEE, JIA-HAI | 1658 | §102§103§112 | Final Rejection | — | Pending | Jun 15, 2023 |
| 18333872 | REPURPOSED COMPOUND AS THERAPEUTIC FOR HPV-ASSOCIATED CANCERS | MCANANY, JOHN D | 1625 | §103 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18326154 | FRAMEWORK FOR PROTEIN DESIGN FROM PARTIAL SEQUENCE WITH MEMORY-EFFICIENT GLOBAL ATTENTION METHOD | HILL, GRACELYN MARKHAM | — | §101§103 | Non-Final OA | — | Pending | May 31, 2023 |
| 18037693 | ASSESSING RISK FOR COLORECTAL ADENOMA RECURRENCE BY NONINVASIVE MEANS | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §101§103§112Other | Final Rejection | — | Pending | May 18, 2023 |
| 18163359 | THREE-DIMENSIONAL ARTIFICIAL INTELLIGENCE-AIDED CLASSIFICATION SYSTEM FOR GLAUCOMATOUS OPTIC NEUROPATHY AND MYOPIC OPTIC DISC MORPHOLOGY FROM OPTICAL COHERENCE TOMOGRAPHY SCANS | DULANEY, BENJAMIN O | 2683 | §103 | Non-Final OA | — | Pending | Feb 02, 2023 |
| 17991701 | CODON DE-OPTIMIZATION OR OPTIMIZATION USING GENETIC ARCHITECTURE | STUBBS, JOHN THOMAS | 1686 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 21, 2022 |
| 17933753 | METHODS AND COMPOSITIONS FOR PROCESSING BOTANICAL MATERIALS | GREENE, CAROLYN LEE | 1681 | §112 | Final Rejection | 97d overdue | Pending | Sep 20, 2022 |
| 17802751 | ACTIVATION OF LYTIC GENES IN CANCER CELLS | ZAHORIK, AMANDA MARY | 1636 | §103 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17814911 | LOW-CONCENTRATION ATROPINE FOR MYOPIA PREVENTION (LAMP-2) STUDY | SHOWALTER, ALEXANDER KEITH | 1629 | §103§112 | Final Rejection | 56d overdue | Pending | Jul 26, 2022 |
| 17742749 | SIZE-BASED GENOMIC ANALYSIS | ELKINS, BLAKE HARRISON | 1687 | §103 | Non-Final OA | 10d overdue | Pending | May 12, 2022 |
| 17533991 | HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR | HURST, JONATHAN M | 1799 | §103 | Final Rejection | 8d overdue | Pending | Nov 23, 2021 |
| 17313880 | SIZE-BASED ANALYSIS OF CELL-FREE TUMOR DNA FOR CLASSIFYING LEVEL OF CANCER | VANNI, GEORGE STEVEN | 1686 | §101§103§112DP | Non-Final OA | — | Pending | May 06, 2021 |
| 17247153 | Methods for Inducing Intermittent Fasting and Modulating Autophagy | DABKOWSKI, ERINNE R | 1654 | §102§112 | Final Rejection | 46d overdue | Pending | Dec 02, 2020 |
| 16949581 | METHOD FOR RECOGNIZING A MOTION PATTERN OF A LIMB | LOPEZ, SEVERO ANTON P | 3791 | §103 | Non-Final OA | 51d overdue | Pending | Nov 04, 2020 |
| 17062387 | PREDICTION MODELS INCORPORATING STRATIFICATION OF DATA | ALGHAZZY, SHAMCY | 2128 | §101§103 | Final Rejection | — | Pending | Oct 02, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial